Andrew Cox
15Patents
1h-index
22Co-inventors
50Inventor score
Filing activity: Oct 2, 2000 → Dec 29, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7364739B2 | Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of Haemophilus influenzae infections | Chemistry; Metallurgy | 4 | Expired |
| US7759070B2 | Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates | Chemistry; Metallurgy | 1 | Active |
| US7585510B1 | Vaccine | Chemistry; Metallurgy | 1 | Expired |
| US8173798B2 | Vaccine | Chemistry; Metallurgy | 1 | Active |
| US10364298B2 | Clostridium difficile lipoteichoic acid and uses thereof | Human Necessities | 0 | Active |
| US8535688B2 | Vaccine | Chemistry; Metallurgy | 0 | Active |
| US7910117B2 | Vaccine | Chemistry; Metallurgy | 0 | Active |
| US11707519B2 | Phosphorylated heptose compounds: process for their preparation and use | Emerging Cross-Sectional Technologies | 0 | Active |
| US12036229B2 | Use of phosphorylated heptose compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US8697092B2 | Identification of a conserved inner core oligosaccharide of Moraxella catarrhalis lipopolysaccharide as a vaccine antigen | Human Necessities | 0 | Active |
| US7923018B2 | Vaccine | Chemistry; Metallurgy | 0 | Active |
| US8148499B2 | Vaccine | Chemistry; Metallurgy | 0 | Active |
| US11795190B2 | D-glycero-B-D-heptose 1-phosphate (HMP) conjugates and use for targeted immune modulation | Emerging Cross-Sectional Technologies | 0 | Active |
| US7825225B2 | Vaccine | Chemistry; Metallurgy | 0 | Active |
| US8975043B2 | Enzymatic degradation of lipid A fatty acids of bacterial LPS | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.